Erqi Pollom

Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

Details about COVID-19, monkeypox, and the flu vaccine

4.7/5

14 Patient Ratings »

38 Patient Reviews »

Professional Summary

Professional Education

BS, Massachusetts Institute of Technology, Chemical Engineering (2008)
MD, University of Michigan Medical School, Medicine (2012)
Transitional Year, MacNeal Hospital (2013)

MS, Stanford, Epidemiology and Clinical Research (2016)

Residency, Stanford, Radiation Oncology (2017)

Board Certification: American Board of Radiology, Radiation Oncology (2018)

Honors & Awards

97th Annual Meeting Travel Award, American Radium Society (2015)
99th Annual Meeting Travel Award, American Radium Society (2017)
Academic Distinction, University of Michigan Medical School (2012)

Glasgow-Rubin Achievement Citation, University of Michigan Medical School (2012)

KL2 Mentored Career Development Award, SPECTRUM (2015-2017)

Malcolm A. Bagshaw Award, Stanford Radiation Oncology (2016)

Medical Honor Society, Alpha Omega Alpha (2012)

Mentorship Award, COMET Medical Scribe Fellowship Program (2022)

Merit Award, American Society of Clinical Oncology (2015)

Poster of Distinction Award, American Radium Society (2017)

Red Journal Outstanding Reviewer Award, International Journal of Radiation Oncology, Biology, and Physics (2021)

Roentgen Research Award, RSNA (2017)

Administrative Appointments

Director, Radiation Oncology Medical Student Clerkship (2018 - 2022)
Director, Clinical Operations, Radiation Oncology (2022 - Present)
Director, Gastrointestinal Cancers, Radiation Oncology (2022 - Present)

Member, Stanford Medicine Committee on Admissions (2021 - Present)

Publications

Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity
Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. A., … Chang, D. T. (2014). Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(4), 918–25.
Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era.
Hiniker, S. M., Pollom, E. L., Khodadoust, M. S., Kozak, M. M., Xu, G., Quon, A., … Hoppe, R. T. (2015). Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era. International Journal of Radiation Oncology, Biology, Physics, 92(1), 99–106.
Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy
Pollom, E. L., Deng, L., Pai, R. K., Brown, J. M., Giaccia, A., Loo, B. W., … Chang, D. T. (2015). Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(3), 568–76.

TU-CD-BRB-08: Radiomic Analysis of FDG-PET Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated with SBRT.
Cui, Y., Song, J., Pollom, E., Shirato, H., Chang, D., Koong, A., & Li, R. (2015). TU-CD-BRB-08: Radiomic Analysis of FDG-PET Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated with SBRT. Medical Physics, 42(6), 3604-?

TU-AB-BRA-10: Prognostic Value of Intra-Radiation Treatment FDG-PET and CT Imaging Features in Locally Advanced Head and Neck Cancer.
Song, J., Cui, Y., Pollom, E., Durkee, B., Aggarwal, S., Bui, T., … Li, R. (2015). TU-AB-BRA-10: Prognostic Value of Intra-Radiation Treatment FDG-PET and CT Imaging Features in Locally Advanced Head and Neck Cancer. Medical Physics, 42(6), 3588-?

Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors
Liu, E., Stenmark, M. H., Schipper, M. J., Balter, J. M., Kessler, M. L., Caoili, E. M., … Feng, M. (2013). Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors. TRANSLATIONAL ONCOLOGY, 6(4), 442–446.

Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1
Vance, S. M., Liu, E., Zhao, L., Parsels, J. D., Parsels, L. A., Brown, J. L., … Morgan, M. A. (2011). Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1. CELL CYCLE, 10(24), 4321–4329.

Resident Workload, Pager Communications, and Quality of Care
Patel, S. P., Lee, J. S., Ranney, D. N., Al-Holou, S. N., Frost, C. M., Harris, M. E., … Lynch, R. J. (2010). Resident Workload, Pager Communications, and Quality of Care. WORLD JOURNAL OF SURGERY, 34(11), 2524–2529.

Connectivity Need Not Come at the Expense of Professionalism
Parikh, S. M., Liu, E., & White, C. B. (2010). Connectivity Need Not Come at the Expense of Professionalism. ACADEMIC MEDICINE, 85(6), 930–930.

Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma.
Pollom, E. L., Bui, T. T., Chang, A. L. S., Colevas, A. D., & Hara, W. Y. (2015). Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma. JAMA Dermatology, 151(9), 998–1001.

Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma.
Pollom, E. L., Koong, A. C., & Ko, A. H. (2015). Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America, 29(4), 741–59.

Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.
Durkee, B. Y., Qian, Y., Pollom, E. L., King, M. T., Dudley, S. A., Shaffer, J. L., … Horst, K. C. (2016). Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer. Journal of Clinical Oncology , 34(9), 902–9.

Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.
Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. A., … Chang, D. T. (2014). Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. International Journal of Radiation Oncology, Biology, Physics, 90(4), 918–25.

A prospective study of electronic quality of life assessment using tablet devices during and after treatment of head and neck cancers.
Pollom, E. L., Wang, E., Bui, T. T., Ognibene, G., von Eyben, R., Divi, V., … Hara, W. Y. (2015). A prospective study of electronic quality of life assessment using tablet devices during and after treatment of head and neck cancers. Oral Oncology, 51(12), 1132–37.

Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
Pollom, E. L., Conklin, C. M. J., von Eyben, R., Folkins, A. K., & Kidd, E. A. (2016). Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer. International Journal of Gynecological Pathology , 35(5), 395–401.

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
Wahl, D. R., Stenmark, M. H., Tao, Y., Pollom, E. L., Caoili, E. M., Lawrence, T. S., … Feng, M. (2015). Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.

Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT.
Alagappan, M., Pollom, E. L., von Eyben, R., Kozak, M. M., Aggarwal, S., Poultsides, G. A., … Chang, D. T. (2016). Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT. American Journal of Clinical Oncology, -?

Prognostic value of midtreatment FDG-PET in oropharyngeal cancer.
Pollom, E. L., Song, J., Durkee, B. Y., Aggarwal, S., Bui, T., von Eyben, R., … Hara, W. Y. (2016). Prognostic value of midtreatment FDG-PET in oropharyngeal cancer. Head & Neck, 38(10), 1472–78.

Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.
Pollom, E. L., Qian, Y., Durkee, B. Y., von Eyben, R., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2016). Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer. Clinical Lung Cancer, 17(6), 588–94.

Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Cui, Y., Song, J., Pollom, E., Alagappan, M., Shirato, H., Chang, D. T., … Li, R. (2016). Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 96(1), 102–9.

Does radiotherapy still have a role in unresected biliary tract cancer?
Pollom, E. L., Alagappan, M., Park, L. S., Whittemore, A. S., Koong, A. C., & Chang, D. T. (2017). Does radiotherapy still have a role in unresected biliary tract cancer? Cancer Medicine, 6(1), 129–41.

Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.
Pollom, E. L., Lee, K., Durkee, B. Y., Grade, M., Mokhtari, D. A., Wahl, D. R., … Chang, D. T. (2017). Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study. Radiology, 161509-?

Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in Elderly Patients.
Pollom, E. L., Chin, A. L., Lee, N. Y., & Tsai, C. J. (2017). Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in Elderly Patients. International Journal of Radiation Oncology, Biology, Physics.

The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell Carcinoma.
Pollom, E. L., Wang, G., Harris, J. P., Koong, A. C., Bendavid, E., Bhattacharya, J., & Chang, D. T. (2017). The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physics.

Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
Pollom, E. L., Fujimoto, D., Wynne, J., Seiger, K., Modlin, L. A., Jacobs, L. R., … Soltys, S. G. (2017). Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results. International Journal of Radiation Oncology, Biology, Physics, 98(1), 123–30.

Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET.
Toesca, D. A. S., Pollom, E. L., Poullos, P. D., Flynt, L., Cui, Y., Quon, A., … Chang, D. T. (2017). Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET. Practical Radiation Oncology, 7(2), 120–25.

Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy.
Pollom, E. L., Chin, A. L., Diehn, M., Loo, B. W., & Chang, D. T. (2017). Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy. Seminars in Radiation Oncology, 27(3), 197–208.

Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors.
Qian, Y., Zhu, H., Pollom, E. L., Durkee, B. Y., Chaudhuri, A. A., Gensheimer, M. F., … Loo, B. W. (2017). Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors. Practical Radiation Oncology.

Cost-Effectiveness of Radiation and Chemotherapy for High-Risk Low-Grade Glioma.
Qian, Y., Maruyama, S., Kim, H., Pollom, E. L., Kumar, K. A., Chin, A. L., … Soltys, S. G. (2017). Cost-Effectiveness of Radiation and Chemotherapy for High-Risk Low-Grade Glioma. Neuro-Oncology.

Reirradiation With Stereotactic Body Radiation Therapy After Prior Conventional Fractionation Radiation for Locally Recurrent Pancreatic Adenocarcinoma
Toesca, D. A. S., Pollom, E., Nwachukwu, C. R., von Eyben, R., Koong, A. C., & Chang, D. T. (2016). Reirradiation With Stereotactic Body Radiation Therapy After Prior Conventional Fractionation Radiation for Locally Recurrent Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E205–E205.

Stereotactic Body Radiation Therapy After Surgical Resection for Locally Recurrent Pancreatic Adenocarcinoma
Nwachukwu, C. R., Toesca, D. A. S., Pollom, E., von Eyben, R., Chang, D. T., & Koong, A. C. (2016). Stereotactic Body Radiation Therapy After Surgical Resection for Locally Recurrent Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E158–E158.

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma.
Koong, A. J., Toesca, D. A., von Eyben, R., Pollom, E. L., & Chang, D. T. Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma. Advances in Radiation Oncology, 2(1), 27–36.

The Impact of FDG Positron Emission Tomography for Assessment of Local Progression of Unresectable Pancreatic Adenocarcinoma After Stereotactic Body Radiation Therapy
Toesca, D. A. S., Pollom, E., Nwachukwu, C. R., von Eyben, R., Koong, A. C., & Chang, D. T. (2016). The Impact of FDG Positron Emission Tomography for Assessment of Local Progression of Unresectable Pancreatic Adenocarcinoma After Stereotactic Body Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E205–E205.

New Hypofractionation Radiation Strategies for Glioblastoma.
Azoulay, M., Shah, J., Pollom, E., & Soltys, S. G. (2017). New Hypofractionation Radiation Strategies for Glioblastoma. Current Oncology Reports, 19(9), 58.

Impact of Intensity-Modulated Radiotherapy on Health Care Costs of Patients With Anal Squamous Cell Carcinoma.
Chin, A. L., Pollom, E. L., Qian, Y., Koong, A. C., & Chang, D. T. (2017). Impact of Intensity-Modulated Radiotherapy on Health Care Costs of Patients With Anal Squamous Cell Carcinoma. Journal of Oncology Practice, JOP2017024810.

Survival Impact of Postoperative Radiotherapy Timing in Pediatric and Adolescent Medulloblastoma.
Chin, A. L., Moding, E. J., Donaldson, S. S., Gibbs, I. C., Soltys, S. G., Hiniker, S. M., & Pollom, E. L. (2018). Survival Impact of Postoperative Radiotherapy Timing in Pediatric and Adolescent Medulloblastoma. Neuro-Oncology.

The Impact of Chemotherapy Regimen and Radiation Dose of Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma
Toesca, D. A. S., Pollom, E. L., von Eyben, R., Koong, A. C., & Chang, D. T. (2017). The Impact of Chemotherapy Regimen and Radiation Dose of Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics, 99(2), E193.

Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival.
Pollom, E. L., Fujimoto, D. K., Han, S. S., Harris, J. P., Tharin, S. A., & Soltys, S. G. (2018). Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. Journal of Radiation Research.

Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski, N. R., Lesniak, M. S., Chandler, J. P., Kalapurakal, J. A., Pollom, E., Tate, M. C., … Sachdev, S. (2018). Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma. Cancer, 124(4), 734–42.

Impact of Insurance Coverage on Outcomes in Primary Breast Sarcoma.
Koenig, J. L., Tsai, C. J., Sborov, K., Horst, K. C., & Pollom, E. L. (2018). Impact of Insurance Coverage on Outcomes in Primary Breast Sarcoma. Sarcoma, 2018, 4626174.

Cost-Effectiveness of Radiation and Chemotherapy for High-Risk Low Grade Glioma
Qian, Y., Maruyama, S., Kim, H., Pollom, E., Kumar, K. A., Harris, J. P., … Soltys, S. G. (2017). Cost-Effectiveness of Radiation and Chemotherapy for High-Risk Low Grade Glioma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), S37.

A Pilot Study of Electronic Quality of Life Assessments Using Tablet Devices During and After Treatment of Head and Neck Cancers
Wang, E., Pollom, E., Bui, T., Ognibene, G., von Eyben, R., Divi, V., … Hara, W. (2016). A Pilot Study of Electronic Quality of Life Assessments Using Tablet Devices During and After Treatment of Head and Neck Cancers. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 94(4), 969.

Cost-Effectiveness of Local Therapies for Inoperable, Localized Hepatocellular Carcinoma
Pollom, E., Lee, K., Durkee, B. Y., Grade, M., Mokhtari, D., Weeks, B., … Chang, D. T. (2016). Cost-Effectiveness of Local Therapies for Inoperable, Localized Hepatocellular Carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E138.

National trends in mastectomy for operable breast cancers treated with neoadjuvant chemotherapy
Pollom, E., Qian, Y., Dirbas, F., Horst, K., & Tsai, C. J. (2018). National trends in mastectomy for operable breast cancers treated with neoadjuvant chemotherapy. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.

Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy.
Kozak, M. M., Jacobson, C. E., von Eyben, R., Walck, E., Pollom, E. L., Telli, M., & Horst, K. C. (2018). Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy. Clinical Breast Cancer.

Value of surveillance studies for patients (pts) with stage I-II diffuse large B-cell lymphoma (DLBCL) in the rituximab (R) era.
Hiniker, S. M., Pollom, E. L., Khodadoust, M. S., Kozak, M. M., Advani, R. H., & Hoppe, R. T. (2014). Value of surveillance studies for patients (pts) with stage I-II diffuse large B-cell lymphoma (DLBCL) in the rituximab (R) era. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Prognostic value of mid-treatment total lesion glycolysis in p16+oropharyngeal cancer
Pollom, E. L., Song, J., Durkee, B. Y., Aggarwal, S., Bui, T., Li, R., … Hara, W. (2015). Prognostic value of mid-treatment total lesion glycolysis in p16+oropharyngeal cancer. JOURNAL OF CLINICAL ONCOLOGY, 33(15).

Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in the Elderly
Chin, A. L., Pollom, E. L., Lee, N. Y., & Tsai, C. J. (2017). Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in the Elderly. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 98(2), E32.

Prognostic Factors, Treatment, and Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era
Hiniker, S. M., Pollom, E. L., Khodadoust, M. S., Kozak, M. M., Advani, R. H., & Hoppe, R. T. (2014). Prognostic Factors, Treatment, and Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

Stereotactic Body Radiotherapy for Pancreatic Adenocarcinoma: Single versus Multi-Fraction
Pollom, E., Alagappan, M., Cox, V., Kamaya, A., Kunz, P., Poultsides, G., … Chang, D. (2014). Stereotactic Body Radiotherapy for Pancreatic Adenocarcinoma: Single versus Multi-Fraction. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S50.

Newly Diagnosed Glioblastoma: Delay in Radiation Therapy Initiation Associated With Adverse Socioeconomic Factors and Worse Survival
Pollom, E., Fujimoto, D. K., Harris, J. P., Chin, A. L., Qian, Y., Tharin, S., & Soltys, S. G. (2017). Newly Diagnosed Glioblastoma: Delay in Radiation Therapy Initiation Associated With Adverse Socioeconomic Factors and Worse Survival. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), E100.

Fractionation of Palliative Radiation Therapy in Metastatic Breast Cancer-Selection and Survival
Qian, Y., Aggarwal, S., Dudley, S. A., Durkee, B. Y., Kumar, K. A., Chaudhuri, A. A., … Horst, K. C. (2016). Fractionation of Palliative Radiation Therapy in Metastatic Breast Cancer-Selection and Survival. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E513.

Outcomes and toxicity of SBRT for patients with unresectable pancreatic adenocarcinoma
Pollom, E. L., Alagappan, M., Chan, C., Shultz, D., Kunz, P. L., Koong, A., & Chang, D. T. (2014). Outcomes and toxicity of SBRT for patients with unresectable pancreatic adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Patterns of Failure After Hypofractionated Intensity Modulated Radiation Therapy for Patients With Non-Small Cell Lung Cancer
Qian, Y., Pollom, E., Durkee, B. Y., von Eyben, R., Gensheimer, M. F., Shultz, D. B., … Loo, B. W. (2016). Patterns of Failure After Hypofractionated Intensity Modulated Radiation Therapy for Patients With Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E422–E423.

Pooled Analysis of Liver Stereotactic Body Radiation Therapy for Colorectal Metastases: Results From 5 Institutions
Shaffer, J., Feng, M. U., Pollom, E., Stenmark, M. H., Tang, M., Monroe, A. T., … Chang, D. T. (2014). Pooled Analysis of Liver Stereotactic Body Radiation Therapy for Colorectal Metastases: Results From 5 Institutions. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S376.

Fractionation of palliative radiotherapy in metastatic breast cancer: Selection and survival
Qian, Y., Dudley, S., Durkee, B. Y., Kumar, K., Chaudhuri, A., Pollom, E. L., … Chang, D. T. (2015). Fractionation of palliative radiotherapy in metastatic breast cancer: Selection and survival. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Pooled Analysis of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Results From a Multi-institution Study
Chang, D. T., Shaffer, J., Pollom, E., Stenmark, M. H., Tang, M., Merrell, K. W., … Feng, M. U. (2014). Pooled Analysis of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Results From a Multi-institution Study. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S376.

Neurocognitive Preservation for Whole-Brain Radiation Therapy is Cost-Effective for Well Selected Patients
Durkee, B. Y., Sanford, J., Oh, A., Slate, D., Turner, B., Pollom, E., … Soltys, S. G. (2015). Neurocognitive Preservation for Whole-Brain Radiation Therapy is Cost-Effective for Well Selected Patients. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), S91.

Pretreatment lab values to predict overall survival in patients with primary unresectable pancreatic adenocarcinoma treated with SBRT
Alagappan, M., Pollom, E. L., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. M., … Chang, D. T. (2015). Pretreatment lab values to predict overall survival in patients with primary unresectable pancreatic adenocarcinoma treated with SBRT. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Cost Effectiveness of Radiation and Chemotherapy for High-Risk Low Grade Glioma
Qian, Y., Maruyama, S., Kim, H., Pollom, E. L., Kumar, K. A., Harris, J. P., … Soltys, S. G. (2018). Cost Effectiveness of Radiation and Chemotherapy for High-Risk Low Grade Glioma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

Cost-effectiveness of pertuzumab in HER2+metastatic breast cancer
Qian, Y., Durkee, B. Y., Pollom, E. L., King, M., Dudley, S. A., Shaffer, J. B., … Horst, K. C. (2016). Cost-effectiveness of pertuzumab in HER2+metastatic breast cancer. CANCER RESEARCH, 76.

Radiomic Analysis of FDG-PET Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With SBRT
Cui, Y., Song, J., Pollom, E., Shirato, H., Chang, D. T., Koong, A. C., & Li, R. (2015). Radiomic Analysis of FDG-PET Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With SBRT. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), S4–S5.

A Single-Institution Study of Pathologic Predictors of Lymph Node Metastasis in Uterine Serous Carcinoma
Pollom, E., Seiger, K., von Eyben, R., Folkins, A., & Kidd, E. A. (2015). A Single-Institution Study of Pathologic Predictors of Lymph Node Metastasis in Uterine Serous Carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), E270.

Impact of IMRT on Health Care Costs Among Elderly Patients with Anal Squamous Cell Carcinoma
Chin, A. L., Pollom, E., Koong, A. C., & Chang, D. T. (2017). Impact of IMRT on Health Care Costs Among Elderly Patients with Anal Squamous Cell Carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), S38.

Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma
Qian, Y., Pollom, E. L., Nwachukwu, C., Seiger, K., von Eyben, R., Folkins, A. K., & Kidd, E. A. (2017). Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma. GYNECOLOGIC ONCOLOGY, 147(1), 24–29.

Surgical Outcomes Following Chemotherapy and Stereotactic Body Radiation Therapy in Patients With Borderline and Unresectable Pancreatic Cancer
Moningi, S., Dholakia, A. S., Raman, S., Hacker-Prietz, A., Pawlik, T., Zheng, L., … Herman, J. M. (2014). Surgical Outcomes Following Chemotherapy and Stereotactic Body Radiation Therapy in Patients With Borderline and Unresectable Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S366–S367.

SBRT Provides Equivalent Local Control Compared to RFA for the Treatment of Hepatocellular Carcinoma With Minimal Toxicity
Wahl, D. R., Stenmark, M. H., Pollom, E., Tao, Y., Lee, O. E., Schipper, M. J., … Feng, M. (2014). SBRT Provides Equivalent Local Control Compared to RFA for the Treatment of Hepatocellular Carcinoma With Minimal Toxicity. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S378–S379.

18F-EF5 Pet-Based Imageable Hypoxia Predicts for Local Control in Tumors Treated With Conformal Radiotherapy
Qian, Y., Liu, Y., Von Eyben, R., Carter, J. N., Pollom, E. L., Harris, J. P., … Loo, B. W. (2018). 18F-EF5 Pet-Based Imageable Hypoxia Predicts for Local Control in Tumors Treated With Conformal Radiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

Lymphovascular Space Invasion Is an Important Prognostic Factor for Lymph Node Metastases in Endometrioid Endometrial Cancer
Pollom, E., Conklin, C., Von Eyben, R., Folkins, A., & Kidd, E. (2014). Lymphovascular Space Invasion Is an Important Prognostic Factor for Lymph Node Metastases in Endometrioid Endometrial Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S186–S187.

Pooled Analysis of Stereotactic Body Radiation Therapy for Liver Tumors: Results From 5 Institutions
Shaffer, J., Feng, M. U., Pollom, E., Stenmark, M. H., Tang, M., Monroe, A. T., … Chang, D. T. (2014). Pooled Analysis of Stereotactic Body Radiation Therapy for Liver Tumors: Results From 5 Institutions. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S380–S381.

Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer.
Cui, Y., Li, B., Pollom, E. L., Horst, K., & Li, R. (2018). Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.

Hippocampus-Sparing Radiation and Chemotherapy
Pollom, E., & Soltys, S. G. (2018). Hippocampus-Sparing Radiation and Chemotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 101(3), 519–20.

Comparing Modalities Using the National Cancer Database: Concerns With Rajyaguru et al.
Pollom, E. L., Feng, M., & Chang, D. T. (2018). Comparing Modalities Using the National Cancer Database: Concerns With Rajyaguru et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2018780403.

Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy.
Pollom, E. L., Qian, Y., Chin, A. L., Dirbas, F. M., Asch, S. M., Kurian, A. W., … Tsai, C. J. (2018). Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy. International Journal of Cancer.

Outcomes Following Neoadjuvant Chemotherapy for Breast Cancer in Women Aged 40 Years and Younger: Impact of Pathologic Nodal Response.
Kozak, M. M., Jacobson, C. E., von Eyben, R., Pollom, E. L., Telli, M., & Horst, K. C. (2018). Outcomes Following Neoadjuvant Chemotherapy for Breast Cancer in Women Aged 40 Years and Younger: Impact of Pathologic Nodal Response. Journal of the National Comprehensive Cancer Network : JNCCN, 16(7), 845–50.

Advance care planning needs in patients with glioblastoma undergoing radiotherapy.
Pollom, E., Sborov, K., Soltys, S. G., Asch, S. M., Sudore, R., & Aslakson, R. A. (2018). Advance care planning needs in patients with glioblastoma undergoing radiotherapy. Journal of Pain and Symptom Management.

Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer.
Harris, J. P., Nwachukwu, C., Qian, Y., Pollom, E., Loo, B. W., Das, M., & Diehn, M. (2018). Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 124, 76–85.

Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data.
Gensheimer, M. F., Henry, A. S., Wood, D. J., Hastie, T. J., Aggarwal, S., Dudley, S. A., … Chang, D. T. (2018). Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data. Journal of the National Cancer Institute.

Sarcopenia in Overweight or Obese Patient is an Adverse Prognostic Factor in Pancreatic Cancer
Nwachukwu, C. R., Wu, Y., Toesca, D. A. S., Von Eyben, R., Pollom, E., & Chang, D. T. (2018). Sarcopenia in Overweight or Obese Patient is an Adverse Prognostic Factor in Pancreatic Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E76.

Use of Preoperative Radiation Therapy in Early and Advanced Stage Breast Cancer
Koenig, J. L., Kozak, M., Sabolch, A., Wapnir, I. L., Horst, K. C., Tsai, C. J., & Pollom, E. (2018). Use of Preoperative Radiation Therapy in Early and Advanced Stage Breast Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E589.

Cost-Effectiveness of Screening for Nasopharyngeal Carcinoma with Plasma Epstein-Barr Virus DNA
Harris, J. P., Saraswathula, A., Kaplun, B. D., Qian, Y., Chan, K. C. A., Chan, A. T. C., … Pollom, E. (2018). Cost-Effectiveness of Screening for Nasopharyngeal Carcinoma with Plasma Epstein-Barr Virus DNA. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E401.

F-18-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated with Highly Conformal Radiation Therapy
Qian, Y., Von Eyben, R., Liu, Y., Chin, F., Miao, Z., Apte, S., … Loo, B. W. (2018). F-18-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated with Highly Conformal Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), S114–S115.

Adverse Radiation Effect and Disease Control in Patients Undergoing Concurrent Stereotactic Radiosurgery and Immunotherapy for Brain Metastases
Koenig, J. L., Sborov, K., Sandhu, N., Gensheimer, M. F., Soltys, S. G., & Pollom, E. (2018). Adverse Radiation Effect and Disease Control in Patients Undergoing Concurrent Stereotactic Radiosurgery and Immunotherapy for Brain Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E275–E276.

Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence after Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability
Turner, B. E., Prabhu, R. S., Burri, S. H., Brown, P. D., Pollom, E., Milano, M. T., … Soltys, S. G. (2018). Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence after Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E363–E364.

Association Between Accuracy of Survival Predictions and Quality of End of Life Care Among Metastatic Cancer Patients Receiving Radiation Therapy
Sborov, K., Giaretta, S., Koong, A., Aggarwal, S., Von Eyben, R., Chang, D. T., … Pollom, E. (2018). Association Between Accuracy of Survival Predictions and Quality of End of Life Care Among Metastatic Cancer Patients Receiving Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), S168.

Quality of End of Life Care among Metastatic Cancer Patients Receiving Radiation Therapy
Sborov, K., Giaretta, S., Koong, A., Aggarwal, S., Von Eyben, R., Chang, D. T., … Pollom, E. (2018). Quality of End of Life Care among Metastatic Cancer Patients Receiving Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E423.

Early Metabolic Response at Mid-Radiation Therapy FDG-PET Imaging Predicts Patterns of Treatment Failure in Locally Advanced Oropharyngeal Cancer
Liang, R., Zhang, N., Wu, J., Sandhu, N., Pollom, E., Le, Q. T., … Li, R. (2018). Early Metabolic Response at Mid-Radiation Therapy FDG-PET Imaging Predicts Patterns of Treatment Failure in Locally Advanced Oropharyngeal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E298–E299.

Estimated Increase in Mean Lifetime Survival for Glioblastoma Patients Age 65 Years and Older Treated with Tumor Treating Fields and Temozolomide Compared to Patients Treated with Temozolomide Alone
Guzauskas, G. F., Pollom, E., & Wang, B. C. M. (2018). Estimated Increase in Mean Lifetime Survival for Glioblastoma Patients Age 65 Years and Older Treated with Tumor Treating Fields and Temozolomide Compared to Patients Treated with Temozolomide Alone. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E244–E245.

The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancer.
Chin, A. L., Bentley, J. P., & Pollom, E. L. (2018). The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancer. Cancer.

Impact of Accuracy of Survival Predictions on Quality of End-of-Life Care Among Patients With Metastatic Cancer Who Receive Radiation Therapy.
Sborov, K., Giaretta, S., Koong, A., Aggarwal, S., Aslakson, R., Gensheimer, M. F., … Pollom, E. L. (2019). Impact of Accuracy of Survival Predictions on Quality of End-of-Life Care Among Patients With Metastatic Cancer Who Receive Radiation Therapy. Journal of Oncology Practice, JOP1800516.

Sinoatrial node dysfunction after stereotactic ablative radiation therapy in the chest
Qian, Y., Dudley, S. A., Kumar, K., Chaudhuri, A., Chin, A., Harris, J. P., … Loo, B. W. (2017). Sinoatrial node dysfunction after stereotactic ablative radiation therapy in the chest. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Cost-effectiveness of Screening for Nasopharyngeal Carcinoma among Asian American Men in the United States.
Harris, J. P., Saraswathula, A., Kaplun, B., Qian, Y., Chan, K. C., Chan, A. T., … Pollom, E. (2019). Cost-effectiveness of Screening for Nasopharyngeal Carcinoma among Asian American Men in the United States. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599819832593.

Automated survival prediction in metastatic cancer patients using high-dimensional electronic medical record data
Gensheimer, M. F., Henry, A. S., Wood, D. J., Hastie, T. J., Aggarwal, S., Dudley, S., … Chang, D. T. (2018). Automated survival prediction in metastatic cancer patients using high-dimensional electronic medical record data. ANNALS OF ONCOLOGY, 29, 548.

THE COST EFFECTIVENESS OF TUMOR TREATING FIELDS TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA BASED ON THE EF-14 TRIAL
Guzauskas, G., Wang, B. C. M., Pollom, E., Stieber, V. W., & Garrison, L. (2018). THE COST EFFECTIVENESS OF TUMOR TREATING FIELDS TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA BASED ON THE EF-14 TRIAL. NEURO-ONCOLOGY, 20, 116.

COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE
Guzauskas, G., Wang, B. C. M., Pollom, E., Stieber, V. W., & Garrison, L. (2018). COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE. NEURO-ONCOLOGY, 20, 116–17.

COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE
Guzauskas, G. F., Wang, B. C. M., Pollom, E. L., Stieber, V. W., Kinzel, A., Proescholdt, C., & Garrison, L. (2018). COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE. NEURO-ONCOLOGY, 20, 254.

Microsatellite instability and adjuvant chemotherapy in stage II colon cancer.
Koenig, J. L., Lin, A. Y., Pollom, E. L., & Chang, D. T. (2018). Microsatellite instability and adjuvant chemotherapy in stage II colon cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases.
Koenig, J. L., Shi, S., Sborov, K., Gensheimer, M. F., Li, G., Nagpal, S., … Pollom, E. L. (2019). Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases. World Neurosurgery.

False News of a Cannabis Cancer Cure
Shi, S., Brant, A. R., Sabolch, A., & Pollom, E. (2019). False News of a Cannabis Cancer Cure. CUREUS, 11(1).

Integrating tumor and nodal imaging characteristics at baseline and mid-treatment CT scans to predict distant metastasis in oropharyngeal cancer treated with concurrent chemoradiotherapy.
Wu, J., Gensheimer, M. F., Zhang, N., Han, F., Liang, R., Qian, Y., … Li, R. (2019). Integrating tumor and nodal imaging characteristics at baseline and mid-treatment CT scans to predict distant metastasis in oropharyngeal cancer treated with concurrent chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics.

The Burden of Mental Health Disorders Among Elderly Patients with Gastrointestinal Malignancies
Harris, J., Xiang, M., Chang, D., & Pollom, E. (2019). The Burden of Mental Health Disorders Among Elderly Patients with Gastrointestinal Malignancies. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 103(5), E30–E31.

Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis.
Kozak, M. M., Xiang, M., Pollom, E. L., & Horst, K. C. (2019). Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis. The Breast Journal.

Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.
Jin, M. C., Wu, A., Xiang, M., Azad, T. D., Soltys, S. G., Li, G., & Pollom, E. L. (2019). Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma. World Neurosurgery.

False News of a Cannabis Cancer Cure.
Shi, S., Brant, A. R., Sabolch, A., & Pollom, E. (2019). False News of a Cannabis Cancer Cure. Cureus, 11(1), e3918.

Tumor treating fields and maintenance temozolomide for newly diagnosed glioblastoma: a cost-effectiveness study.
Guzauskas, G. F., Pollom, E. L., Stieber, V. W., Wang, B. C., & Garrison, L. (2019). Tumor treating fields and maintenance temozolomide for newly diagnosed glioblastoma: a cost-effectiveness study. Journal of Medical Economics, 1.

Physiological motion of the optic chiasm and its impact on stereotactic radiosurgery dose.
Xiang, M., Chan, C., Wang, L., Jani, K., Holdsworth, S. J., Iv, M., … Soltys, S. (2019). Physiological motion of the optic chiasm and its impact on stereotactic radiosurgery dose. The British Journal of Radiology, 20190170.

Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System.
Toesca, D. A., Jeffrey, R. B., von Eyben, R., Pollom, E. L., Poullos, P. D., Poultsides, G. A., … Chang, D. T. Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. Pancreas, 48(5), 622–28.

Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer
Harris, J. P., Nwachukwu, C., Qian, Y., Pollom, E., Loo, B. W., Das, M., & Diehn, M. (2018). Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer. LUNG CANCER, 124, 76–85.

Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma
Chin, A. L., Moding, E. J., Donaldson, S. S., Gibbs, I. C., Soltys, S. G., Hiniker, S. M., & Pollom, E. L. (2018). Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma. NEURO-ONCOLOGY, 20(8), 1133–41.

F-18-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy
Qian, Y., Von Eyben, R., Liu, Y., Chin, F. T., Miao, Z., Apte, S., … Loo Jr, B. W. (2018). F-18-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(4), 1183–92.

Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
Fatima, N., Meola, A., Pollom, E. L., Soltys, S. G., & Chang, S. D. (2019). Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis. Neurosurgical Focus, 46(6), E2.

Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.
Koenig, J. L., Toesca, D. A., Harris, J. P., Tsai, C. J., Haraldsdottir, S., Lin, A. Y., … Chang, D. T. (2019). Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer. American Journal of Clinical Oncology.

Tumor treating fields treatment for patients with newly diagnosed glioblastoma: A cost-effectiveness analysis
Guzauskas, G. F., Pollom, E. L., Stieber, V. W., Wang, B. C., & Garrison, L. (2018). Tumor treating fields treatment for patients with newly diagnosed glioblastoma: A cost-effectiveness analysis. CANCER RESEARCH, 78(13).

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study
Guzauskas, G. F., Pollom, E. L., Stieber, V. W., Wang, B. C. M., & Garrison, L. P. (2019). Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study. JOURNAL OF MEDICAL ECONOMICS.

The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancer
Chin, A. L., Bentley, J. P., & Pollom, E. L. (2019). The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancer. CANCER, 125(3), 374–81.

Advance Care Planning Needs in Patients With Glioblastoma Undergoing Radiotherapy
Pollom, E. L., Sborov, K. D., Soltys, S. G., Asch, S. M., Sudore, R. L., & Aslakson, R. A. (2018). Advance Care Planning Needs in Patients With Glioblastoma Undergoing Radiotherapy. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 56(6), E6–E8.

Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy
Pollom, E. L., Qian, Y., Chin, A. L., Dirbas, F. M., Asch, S. M., Kurian, A. W., … Tsai, C. J. (2018). Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy. INTERNATIONAL JOURNAL OF CANCER, 143(12), 3262–72.

Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer
Cui, Y., Li, B., Pollom, E. L., Horst, K. C., & Li, R. (2018). Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer. CLINICAL CANCER RESEARCH, 24(19), 4754–62.

Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy
Kozak, M. M., Jacobson, C. E., von Eyben, R., Walck, E., Pollom, E. L., Telli, M., & Horst, K. C. (2018). Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy. CLINICAL BREAST CANCER, 18(5), E1077–E1085.

Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases
Koenig, J. L., Shi, S., Sborov, K., Gensheimer, M. F., Le, G., Nagpal, S., … Pollom, E. L. (2019). Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases. WORLD NEUROSURGERY, 126, E1399–E1411.

Stereotactic radiosurgery in large intracranial meningiomas: a systematic review.
Fatima, N., Meola, A., Pollom, E., Chaudhary, N., Soltys, S., & Chang, S. (2019). Stereotactic radiosurgery in large intracranial meningiomas: a systematic review. World Neurosurgery.

Survival after neoadjuvant approaches to gastroesophageal junction cancer.
Xiang, M., Chang, D. T., Heestand, G. M., & Pollom, E. L. (2019). Survival after neoadjuvant approaches to gastroesophageal junction cancer. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association.

Integrating Tumor and Nodal Imaging Characteristics at Baseline and Mid-Treatment Computed Tomography Scans to Predict Distant Metastasis in Oropharyngeal Cancer Treated With Concurrent Chemoradiotherapy
Wu, J., Gensheimer, M. F., Zhang, N., Han, F., Liang, R., Qian, Y., … Li, R. (2019). Integrating Tumor and Nodal Imaging Characteristics at Baseline and Mid-Treatment Computed Tomography Scans to Predict Distant Metastasis in Oropharyngeal Cancer Treated With Concurrent Chemoradiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 104(4), 942–52.

Physiological motion of the optic chiasm and its impact on stereotactic radiosurgery dose
Xiang, M., Chan, C., Wang, L., Jani, K., Holdsworth, S. J., Iv, M., … Soltys, S. G. (2019). Physiological motion of the optic chiasm and its impact on stereotactic radiosurgery dose. BRITISH JOURNAL OF RADIOLOGY, 92(1099).

Socioeconomic resources and survival in patients with metastatic breast cancer treated with palliative radiotherapy
Qian, Y., Aggarwal, S., Dudley, S. A., Durkee, B. Y., Kumar, K., Chaudhuri, A., … Horst, K. C. (2016). Socioeconomic resources and survival in patients with metastatic breast cancer treated with palliative radiotherapy. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Cost-effectiveness of Screening for Nasopharyngeal Carcinoma among Asian American Men in the United States
Harris, J. P., Saraswathula, A., Kaplun, B., Qian, Y., Chan, K. C. A., Chan, A. T. C., … Pollom, E. (2019). Cost-effectiveness of Screening for Nasopharyngeal Carcinoma among Asian American Men in the United States. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 161(1), 82–90.

Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data
Gensheimer, M. F., Henry, A. S., Wood, D. J., Hastie, T. J., Aggarwal, S., Dudley, S. A., … Chang, D. T. (2019). Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 111(6), 568–74.

Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma
Jin, M. C., Wu, A., Xiang, M., Azad, T. D., Soltys, S. G., Li, G., & Pollom, E. L. (2019). Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma. WORLD NEUROSURGERY, 128, E217–E224.

Successful Use of Frameless Stereotactic Radiosurgery for Treatment of Recurrent Brain Metastases in an 18 Month Old Child.
Rahimy, E., Chuang, C., Spunt, S. L., Mahaney, K., Donaldson, S. S., Gibbs, I. C., … Hiniker, S. M. (2019). Successful Use of Frameless Stereotactic Radiosurgery for Treatment of Recurrent Brain Metastases in an 18 Month Old Child. The International Journal of Neuroscience, 1–6.

Tumor Subregion Evolution-based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer.
Wu, J., Gensheimer, M., Zhang, N., Guo, M., Liang, R., Zhang, C., … Li, R. (2019). Tumor Subregion Evolution-based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine.

Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System
Toesca, D. A. S., Jeffrey, R. B., von Eyben, R., Pollom, E. L., Poullos, P. D., Poultsides, G. A., … Chang, D. T. (2019). Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. PANCREAS, 48(5), 622–28.

Stereotactic Radiosurgery for Resected Brain Metastases: Single-Institutional Experience of over 500 Cavities
Shi, S., Sandhu, N., Wang, E. H., Liu, E., Jaoude, J. A., Jin, M., … Pollom, E. (2019). Stereotactic Radiosurgery for Resected Brain Metastases: Single-Institutional Experience of over 500 Cavities. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E90.

Stereotactic Radiosurgery for Small Cell Lung Cancer Brain Metastases
Bagshaw, H. P., Taggarsi, R. S., Moding, E. J., Fawaz, Z. S., Von Eyben, R., Pollom, E., … Soltys, S. G. (2019). Stereotactic Radiosurgery for Small Cell Lung Cancer Brain Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E70–E71.

Factors Associated with Treatment Failure and Radiation Necrosis Following Cavity Radiosurgery for Resected Brain Metastases
Wang, E. H., Shi, S., Sandhu, N., Liu, E., Jin, M., Schofield, K., … Pollom, E. (2019). Factors Associated with Treatment Failure and Radiation Necrosis Following Cavity Radiosurgery for Resected Brain Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E92.

Vertebral Compression Fracture Rates after Stereotactic Radiosurgery for Spinal Metastases
Usoz, M., Dhillon, J., Kumar, K. A., Von Eyben, R., White, E. C., Ho, C. K., … Soltys, S. G. (2019). Vertebral Compression Fracture Rates after Stereotactic Radiosurgery for Spinal Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E126–E127.

Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy
Benson, K., Sandhu, N., Zhang, C., Ko, R. B., Toesca, D. A. S., Von Eyben, R., … Chang, D. T. (2019). Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E161–E162.

Stereotactic Radiosurgery for Spine Metastases of Gastrointestinal Origin
Sandhu, N., Benson, K., Kumar, K. A., Von Eyben, R., Chang, D. T., Soltys, S. G., & Pollom, E. (2019). Stereotactic Radiosurgery for Spine Metastases of Gastrointestinal Origin. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E125–E126.

Financial Toxicity in Metastatic Cancer Patients Receiving Stereotactic Radiosurgery
Koenig, J. L., Sborov, K., Sandhu, N., Sabolch, A., Usoz, M., Hiniker, S. M., … Pollom, E. (2019). Financial Toxicity in Metastatic Cancer Patients Receiving Stereotactic Radiosurgery. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E596–E597.

Impact of Lymphopenia on Survival Following Stereotactic Radiosurgery and Immune-Checkpoint Inhibitors Among Patients with Brain Metastases
Benitez, C. M., Koenig, J. L., Sborov, K., Gibbs, I. C., Gensheimer, M. F., Soltys, S. G., & Pollom, E. (2019). Impact of Lymphopenia on Survival Following Stereotactic Radiosurgery and Immune-Checkpoint Inhibitors Among Patients with Brain Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), S144.

Analysis of the EF-14 Phase 3 Trial Reveals That Tumor-Treating Fields Alter Progression Patterns in Glioblastoma
Jeyapalan, S., Toms, S. A., Hottinger, A., Kleinberg, L. R., Pollom, E., Soltys, S. G., & Glas, M. (2019). Analysis of the EF-14 Phase 3 Trial Reveals That Tumor-Treating Fields Alter Progression Patterns in Glioblastoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E100–E101.

Cost Effectiveness of Watch-and-Wait or Total Mesorectal Excision after Complete Clinical Response to Chemoradiotherapy for Rectal Cancer
Miller, J. A., Wang, H., Chang, D. T., & Pollom, E. (2019). Cost Effectiveness of Watch-and-Wait or Total Mesorectal Excision after Complete Clinical Response to Chemoradiotherapy for Rectal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E171.

Tolerability and Toxicity of Definitive and Preoperative Chemoradiation in Octogenarian Patients with Esophageal Cancer
Rahimy, E., Koong, A., Toesca, D. A. S., Panjwani, N., Fisher, G. A., Chang, D. T., & Pollom, E. (2019). Tolerability and Toxicity of Definitive and Preoperative Chemoradiation in Octogenarian Patients with Esophageal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E196.

Clinical and Economic Impact of Mental Health Illnesses Surrounding a Gastrointestinal Malignancy Among Elderly Patients
Harris, J. P., Panjwani, N., Chang, D. T., & Pollom, E. (2019). Clinical and Economic Impact of Mental Health Illnesses Surrounding a Gastrointestinal Malignancy Among Elderly Patients. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E595–E596.

Outcomes of Chemoradiation and Trimodality Therapy Among Elderly Patients with Locally Advanced Esophageal Cancer
Panjwani, N., Chin, A. L., Xiang, M., Rahimy, E., Chang, D. T., & Pollom, E. (2019). Outcomes of Chemoradiation and Trimodality Therapy Among Elderly Patients with Locally Advanced Esophageal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E193–E194.

Defining the Optimal Neoadjuvant Treatment Strategy in Patients with Resectable Pancreas Cancer
Xiang, M., Chang, D. T., Heestand, M., & Pollom, E. (2019). Defining the Optimal Neoadjuvant Treatment Strategy in Patients with Resectable Pancreas Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E249.

Stereotactic Body Radiotherapy for Cholangiocarcinoma: Optimizing Locoregional Control with Elective Nodal Irradiation
Kozak, M., Toesca, D. A. S., Von Eyben, R., Pollom, E., & Chang, D. T. (2019). Stereotactic Body Radiotherapy for Cholangiocarcinoma: Optimizing Locoregional Control with Elective Nodal Irradiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E223–E224.

Improved Survival with Modified Folfirinox and Higher Doses of Stereotactic Body Radiation Therapy for Treatment of Locally Advanced Pancreatic Adenocarcinoma
Ahmed, F., Toesca, D. A. S., Von Eyben, R., Kashyap, M., Pollom, E., & Chang, D. T. (2019). Improved Survival with Modified Folfirinox and Higher Doses of Stereotactic Body Radiation Therapy for Treatment of Locally Advanced Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E232–E233.

Habitat Evolution Imaging Biomarkers to Assess Early Response and Predict Treatment Outcomes in Oropharyngeal Cancer
Wu, J., Gensheimer, M., Liang, R., Zhang, C., Pollom, E., Beadle, B. M., … Li, R. (2019). Habitat Evolution Imaging Biomarkers to Assess Early Response and Predict Treatment Outcomes in Oropharyngeal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), S32.

Patterns and Disparities of Ablative Radiation Therapy Use in Patients with Metastatic Cancer: a Study of the National Cancer Database
Koenig, J. L., Shi, W., Hannum, M., Yang, T. J., Gillespie, E. F., Zhang, Z., … Tsai, C. J. (2019). Patterns and Disparities of Ablative Radiation Therapy Use in Patients with Metastatic Cancer: a Study of the National Cancer Database. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E567.

Treating Elderly Glioblastoma Patients > 65 Years with TTFields - a Cost-Effectiveness Perspective
Guzauskas, G. F., Pollom, E., Leonard, F., & Stieber, V. W. (2019). Treating Elderly Glioblastoma Patients > 65 Years with TTFields - a Cost-Effectiveness Perspective. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E439–E440.

Stereotactic Radiosurgery for Pediatric and Adult Intracranial and Spinal Ependymomas.
Shi, S., Jin, M. C., Koenig, J., Gibbs, I. C., Soltys, S. G., Chang, S. D., … Pollom, E. L. (2019). Stereotactic Radiosurgery for Pediatric and Adult Intracranial and Spinal Ependymomas. Stereotactic and Functional Neurosurgery, 1–6.

Use of Preoperative Radiation Therapy in Early-stage and Locally Advanced Breast Cancer
Koenig, J. L., Kozak, M. M., Sabolch, A., Horst, K., Tsai, J., Wapnir, I. L., & Pollom, E. (2019). Use of Preoperative Radiation Therapy in Early-stage and Locally Advanced Breast Cancer. CUREUS, 11(9).

Stereotactic radiosurgery for resected brain metastases: Does the surgical corridor need to be treated?
Shi, S., Jaoude, J. A., Sandhu, N., Wang, E., Schofield, K., Jin, M. C., … Soltys, S. G. (2019). Stereotactic radiosurgery for resected brain metastases: Does the surgical corridor need to be treated? JOURNAL OF CLINICAL ONCOLOGY, 37(15).

Analysis of the EF-14 phase Ill trial reveals that tumor treating fields alter progression patterns in glioblastoma.
Jeyapalan, S. A., Toms, S. A., Hottinger, A. F., Kleinberg, L., Pollom, E., Soltys, S. G., & Glas, M. (2019). Analysis of the EF-14 phase Ill trial reveals that tumor treating fields alter progression patterns in glioblastoma. JOURNAL OF CLINICAL ONCOLOGY, 37(15).

Risk of subsequent cancer diagnosis in patients treated with 3D conformal, intensity modulated, or proton beam radiation therapy.
Xiang, M. H., Chang, D. T., & Pollom, E. L. (2019). Risk of subsequent cancer diagnosis in patients treated with 3D conformal, intensity modulated, or proton beam radiation therapy. JOURNAL OF CLINICAL ONCOLOGY, 37(15).

Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability.
Turner, B. E., Prabhu, R. S., Burri, S. H., Brown, P. D., Pollom, E. L., Milano, M. T., … Soltys, S. G. (2019). Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability. International Journal of Radiation Oncology, Biology, Physics.

Stereotactic Radiosurgery for Large Benign Intracranial Tumors.
Fatima, N., Meola, A., Pollom, E., Chang, S. D., & Soltys, S. (2019). Stereotactic Radiosurgery for Large Benign Intracranial Tumors. World Neurosurgery.

Tumor Treating Fields alters progression patterns in glioblastoma: An imaging analysis of the EF-14 Phase III trial
Jeyapalan, S., Toms, S. A., Hottinger, A., Kleinberg, L., Pollom, E., Soltys, S. G., & Glas, M. (2019). Tumor Treating Fields alters progression patterns in glioblastoma: An imaging analysis of the EF-14 Phase III trial. CANCER RESEARCH, 79(13).

Treating elderly glioblastoma patients > 65 years with TTFields - a cost-effectiveness perspective
Guzauskas, G. F., Pollom, E. L., & Stieber, V. W. (2019). Treating elderly glioblastoma patients > 65 years with TTFields - a cost-effectiveness perspective. CANCER RESEARCH, 79(13).

Downstaging and survival after neoadjuvant approaches to gastroesophageal junction adenocarcinoma.
Xiang, M. H., Chang, D. T., Heestand, G. M., & Pollom, E. L. (2019). Downstaging and survival after neoadjuvant approaches to gastroesophageal junction adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY, 37(4).

TTFIELDS DOSE DISTRIBUTION AND TUMOR GROWTH PATTERNS CONFIRM CLINICAL ACTIVITY OF TTFIELDS: MRI ANALYSIS OF THE RANDOMIZED PHASE 3 EF-14 TRIAL
Kebir, S., Ballo, M. T., Jeyapalan, S., Toms, S. A., Hottinger, A., Pollom, E., & Glas, M. (2019). TTFIELDS DOSE DISTRIBUTION AND TUMOR GROWTH PATTERNS CONFIRM CLINICAL ACTIVITY OF TTFIELDS: MRI ANALYSIS OF THE RANDOMIZED PHASE 3 EF-14 TRIAL. NEURO-ONCOLOGY, 21, 82–83.

Use of Preoperative Radiation Therapy in Early-stage and Locally Advanced Breast Cancer.
Koenig, J. L., Kozak, M. M., Sabolch, A., Horst, K., Tsai, J., Wapnir, I. L., & Pollom, E. (2019). Use of Preoperative Radiation Therapy in Early-stage and Locally Advanced Breast Cancer. Cureus, 11(9), e5748.

Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities.
Shi, S., Sandhu, N., Jin, M. C., Wang, E., Jaoude, J. A., Schofield, K., … Pollom, E. L. (2019). Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities. International Journal of Radiation Oncology, Biology, Physics.

Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.
Jin, M. C., Harris, J. P., Sabolch, A. N., Gensheimer, M., Le, Q.-T., Beadle, B. M., & Pollom, E. L. (2019). Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma. The Laryngoscope.

Cost-Effectiveness and Quality-Adjusted Survival of Watch-and-Wait after Complete Response to Chemoradiotherapy for Rectal Cancer.
Miller, J. A., Wang, H., Chang, D. T., & Pollom, E. L. (2020). Cost-Effectiveness and Quality-Adjusted Survival of Watch-and-Wait after Complete Response to Chemoradiotherapy for Rectal Cancer. Journal of the National Cancer Institute.

A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes.
Azoulay, M., Chang, S. D., Gibbs, I. C., Hancock, S. L., Pollom, E. L., Harsh, G. R., … Soltys, S. G. (2020). A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes. Neuro-Oncology.

Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database.
Xiang, M., Heestand, G. M., Chang, D. T., & Pollom, E. L. (2020). Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic Body Radiation Therapy for Cholangiocarcinoma: Optimizing Locoregional Control With Elective Nodal Irradiation.
Kozak, M. M., Toesca, D. A., von Eyben, R., Pollom, E. L., & Chang, D. T. (2020). Stereotactic Body Radiation Therapy for Cholangiocarcinoma: Optimizing Locoregional Control With Elective Nodal Irradiation. Advances in Radiation Oncology, 5(1), 77–84.

Patterns of Care and Age-Specific Impact of Extent of Resection and Adjuvant Radiotherapy in Pediatric Pineoblastoma.
Jin, M. C., Prolo, L. M., Wu, A., Azad, T. D., Shi, S., Rodrigues, A. J., … Grant, G. A. (2020). Patterns of Care and Age-Specific Impact of Extent of Resection and Adjuvant Radiotherapy in Pediatric Pineoblastoma. Neurosurgery.

Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin.
Sandhu, N., Benson, K. R., Kumar, K. A., Eyben, R. V., Chang, D. T., Gibbs, I. C., … Pollom, E. L. (2020). Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin. Journal of Neurosurgery. Spine, 1–8.

The Utility of Stereotactic Body Radiotherapy for Palliation of Metastatic Pancreatic Adenocarcinoma.
Koong, A. J., Toesca, D. A., Baclay, J. R., Pollom, E. L., von Eyben, R., Koong, A. C., & Chang, D. T. (2020). The Utility of Stereotactic Body Radiotherapy for Palliation of Metastatic Pancreatic Adenocarcinoma. Practical Radiation Oncology.

Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.
Jin, M. C., Liu, E. K., Shi, S., Gibbs, I. C., Thomas, R., Recht, L., … Li, G. (2020). Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma. Frontiers in Oncology, 10, 337.

Clinical impact of the VOLO optimizer on treatment plan quality and clinical treatment efficiency for CyberKnife.
Schuler, E., Lo, A., Chuang, C. F., Soltys, S. G., Pollom, E. L., & Wang, L. (2020). Clinical impact of the VOLO optimizer on treatment plan quality and clinical treatment efficiency for CyberKnife. Journal of Applied Clinical Medical Physics.

Automated survival prediction in metastatic cancer patients using high-dimensional electronic medical record data.
Gensheimer, M. F., Henry, A. S., Wood, D. J., Hastie, T. J., Aggarwal, S., Dudley, S., … Chang, D. T. (2018). Automated survival prediction in metastatic cancer patients using high-dimensional electronic medical record data. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 29 Suppl 8, viii548.

Signet ring cell carcinoma of the Ampulla of Vater: outcomes of patients in the United States.
Kinslow, C. J., May, M. S., Kozak, M., Pollom, E. L., & Chang, D. T. (2020). Signet ring cell carcinoma of the Ampulla of Vater: outcomes of patients in the United States. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.

Stereotactic radiosurgery for head and neck paragangliomas: a systematic review and meta-analysis.
Fatima, N., Pollom, E., Soltys, S., Chang, S. D., & Meola, A. (2020). Stereotactic radiosurgery for head and neck paragangliomas: a systematic review and meta-analysis. Neurosurgical Review.

Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game?
Chang, D. T., Pollom, E. L., Keane, F. K., & Wo, J. Y. (2020). Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game? International Journal of Radiation Oncology, Biology, Physics, 107(2), 257–60.

Stereotactic Radiosurgery for Resected Brain Metastases - Does the Surgical Corridor Need to be Targeted?
Shi, S., Sandhu, N., Jin, M., Wang, E., Liu, E., Jaoude, J. A., … Soltys, S. G. (2020). Stereotactic Radiosurgery for Resected Brain Metastases - Does the Surgical Corridor Need to be Targeted? Practical Radiation Oncology.

Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy.
Xiang, M., Chang, D. T., & Pollom, E. L. (2020). Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy. Cancer.

Clinical outcomes of hepatocellular carcinoma patients with Child-Pugh class B treated with stereotactic body radiation therapy
Baclay, J. R., Toesca, D. A. S., von Eyben, R., Minneci, M., Pollom, E. L., & Chang, D. T. (2020). Clinical outcomes of hepatocellular carcinoma patients with Child-Pugh class B treated with stereotactic body radiation therapy. JOURNAL OF CLINICAL ONCOLOGY, 38(4).

Emergency department use at the end of life in elderly patients with gastrointestinal malignancies and mental health comorbidities
Kashyap, M., Harris, J. P., Chang, D. T., & Pollom, E. L. (2020). Emergency department use at the end of life in elderly patients with gastrointestinal malignancies and mental health comorbidities. JOURNAL OF CLINICAL ONCOLOGY, 38(4).

Impact of Proton Radiotherapy on Treatment Timing in Pediatric and Adult Patients with Central Nervous System Tumors
Jin, M. C., Shi, S., Wu, A., Sandhu, N., Xiang, M., Soltys, S. G., … Pollom, E. L. (2020). Impact of Proton Radiotherapy on Treatment Timing in Pediatric and Adult Patients with Central Nervous System Tumors. Neuro-Oncology Practice.

Intensified Systemic Therapy and Stereotactic Ablative Radiotherapy Dose for Patients with Unresectable Pancreatic Adenocarcinoma.
Toesca, D. A., Ahmed, F., Kashyap, M., Richelcyn M Baclay, J., von Eyben, R., Pollom, E. L., … Chang, D. T. (2020). Intensified Systemic Therapy and Stereotactic Ablative Radiotherapy Dose for Patients with Unresectable Pancreatic Adenocarcinoma. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology.

Continuing Medical Student Education During the Coronavirus Disease 2019 (COVID-19) Pandemic: Development of a Virtual Radiation Oncology Clerkship.
Pollom, E. L., Sandhu, N., Frank, J., Miller, J. A., Obeid, J.-P., Kastelowitz, N., … Gibbs, I. (2020). Continuing Medical Student Education During the Coronavirus Disease 2019 (COVID-19) Pandemic: Development of a Virtual Radiation Oncology Clerkship. Advances in Radiation Oncology, 5(4), 732–36.

Intracranial Tumor Control Following Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma.
Zhang, M., Rodrigues, A. J., Bhambhvani, H. P., Fatemi, P., Pollom, E. L., Gibbs, I. C., … Li, G. (2020). Intracranial Tumor Control Following Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma. World Neurosurgery.

Virtual Radiation Oncology Clerkship During the COVID-19 Pandemic and Beyond.
Sandhu, N., Frank, J., von Eyben, R., Miller, J., Obeid, J.-P., Kastelowitz, N., … Pollom, E. (2020). Virtual Radiation Oncology Clerkship During the COVID-19 Pandemic and Beyond. International Journal of Radiation Oncology, Biology, Physics, 108(2), 444–51.

Increasing Medical Student Engagement through Virtual Rotations in Radiation Oncology.
Kahn, J. M., Fields, E. C., Pollom, E., Wairiri, L., Vapiwala, N., Nabavizadeh, N., … Chandra, R. A. (2020). Increasing Medical Student Engagement through Virtual Rotations in Radiation Oncology. Advances in Radiation Oncology.

Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States.
Chin, A. L., Li, G., Gephart, M. H., Sandhu, N., Nagpal, S., Soltys, S. G., & Pollom, E. L. (2020). Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States. World Neurosurgery.

The clinical and financial cost of mental disorders among elderly patients with gastrointestinal malignancies.
Harris, J. P., Kashyap, M., Humphreys, J. N., Pollom, E. L., & Chang, D. T. (2020). The clinical and financial cost of mental disorders among elderly patients with gastrointestinal malignancies. Cancer Medicine.

Neoadjuvant chemotherapy (NACT) use and response in US patients with early-stage triple-negative breast cancer in the National Cancer Database (NCDB)
Kashyap, M., Downer, M., Debiasi, M., Russell, K., Craggs, C., Luhn, P., & Pollom, E. (2020). Neoadjuvant chemotherapy (NACT) use and response in US patients with early-stage triple-negative breast cancer in the National Cancer Database (NCDB). ANNALS OF ONCOLOGY, 31, S320–S321.

Repeat Stereotactic Radiosurgery (SRS) For Brain Metastases Locally Recurrent Following Initial SRS
Harandi, N. K., Modlin, L. A., Shi, S., Von Eyben, R., Pollom, E., & Soltys, S. G. (2020). Repeat Stereotactic Radiosurgery (SRS) For Brain Metastases Locally Recurrent Following Initial SRS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), E733.

Health-Related Quality of Life following Fractionated Stereotactic Radiosurgery for Large Brain Metastases Resection Cavities on a Phase I/II Trial
Rahimy, E., Dudley, S. A., Von Eyben, R., Pollom, E., & Soltys, S. G. (2020). Health-Related Quality of Life following Fractionated Stereotactic Radiosurgery for Large Brain Metastases Resection Cavities on a Phase I/II Trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), S68–S69.

Survival Benefit of Postoperative Radiotherapy in Pathological N1 Oral Cavity Squamous Cell Carcinoma
Xiang, M., Holsinger, F. C., Gensheimer, M. F., Divi, V., Pollom, E., Colevas, A. D., … Beadle, B. M. (2020). Survival Benefit of Postoperative Radiotherapy in Pathological N1 Oral Cavity Squamous Cell Carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

Patterns of Regional Failure in Patients with Pancreatic Cancer treated with Stereotactic Body Radiation Therapy
Baclay, J. R. M., Toesca, D. A. S., Von Eyben, R., Pollom, E., & Chang, D. T. (2020). Patterns of Regional Failure in Patients with Pancreatic Cancer treated with Stereotactic Body Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), E584–E585.

Quality of End-of-Life Care Among Elderly Patients With Gastrointestinal Cancers and Comorbid Substance Use Disorders
Kashyap, M., Harris, J. P., Chang, D. T., & Pollom, E. (2020). Quality of End-of-Life Care Among Elderly Patients With Gastrointestinal Cancers and Comorbid Substance Use Disorders. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), E405–E406.

Feasibility and Acute Toxicity of Pancreatic Stereotactic Body Radiotherapy with or without Hypofractionated Elective Nodal Irradiation
Miller, J. A., Toesca, D. A. S., Baclay, J. R. M., Pollom, E., & Chang, D. T. (2020). Feasibility and Acute Toxicity of Pancreatic Stereotactic Body Radiotherapy with or without Hypofractionated Elective Nodal Irradiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), E580–E581.

Hematologic Toxicity Patterns In Patients Treated With Chemoradiation For Anal Squamous Cell Carcinoma
Minneci, M., Baclay, J. R. M., Toesca, D. A. S., Von Eyben, R., Pollom, E., & Chang, D. T. (2020). Hematologic Toxicity Patterns In Patients Treated With Chemoradiation For Anal Squamous Cell Carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), E641–E642.

PREOPERATIVE SINGLE FRACTION RADIOSURGERY VERSUS POSTOPERATIVE FRACTIONATED RADIOSURGERY FOR RESECTED BRAIN METASTASES: A BI-INSTITUTIONAL ANALYSIS OF SAFETY AND CLINICAL OUTCOMES
Prabhu, R., Shi, S., Dhakal, R., Soltys, S., Burri, S., Asher, A., … Pollom, E. (2020). PREOPERATIVE SINGLE FRACTION RADIOSURGERY VERSUS POSTOPERATIVE FRACTIONATED RADIOSURGERY FOR RESECTED BRAIN METASTASES: A BI-INSTITUTIONAL ANALYSIS OF SAFETY AND CLINICAL OUTCOMES. NEURO-ONCOLOGY, 22, 184.

Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review.
Rahimy, E., Koong, A., Toesca, D., White, M. N., Panjwani, N., Fisher, G., … Pollom, E. (2020). Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review. Advances in Radiation Oncology, 5(6), 1188–96.

Automated model versus treating physician for predicting survival time of patients with metastatic cancer.
Gensheimer, M. F., Aggarwal, S., Benson, K. R., Carter, J. N., Henry, A. S., Wood, D. J., … Chang, D. T. (2020). Automated model versus treating physician for predicting survival time of patients with metastatic cancer. Journal of the American Medical Informatics Association : JAMIA.

Impact of proton radiotherapy on treatment timing in pediatric and adult patients with CNS tumors.
Jin, M. C., Shi, S., Wu, A., Sandhu, N., Xiang, M., Soltys, S. G., … Pollom, E. L. (2020). Impact of proton radiotherapy on treatment timing in pediatric and adult patients with CNS tumors. Neuro-Oncology Practice, 7(6), 626–635.

Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.
Zhang, M., Li, R., Pollom, E. L., Amini, A., Dandapani, S., & Li, G. (2020). Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 82(Pt A), 122–27.

Treatment Breaks During Definitive Head/Neck Radiotherapy: Survival Impact and Predisposing Factors
Xiang, M., Gensheimer, M., Pollom, E., Holsinger, F. C., Colevas, A. D., Quynh-Thu Le, & Beadle, B. (2020). Treatment Breaks During Definitive Head/Neck Radiotherapy: Survival Impact and Predisposing Factors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.
Xiang, M., Gensheimer, M. F., Pollom, E. L., Holsinger, F. C., Colevas, A. D., Le, Q.-T. T., & Beadle, B. M. (2020). Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology.

Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
Zhang, M., Rodrigues, A. J., Pollom, E. L., Gibbs, I. C., Soltys, S. G., Hancock, S. L., … Li, G. (2021). Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases. Journal of Neuro-Oncology.

Longitudinal Analysis of Mental Disorder Burden Among Elderly Patients With Gastrointestinal Malignancies.
Harris, J. P., Kashyap, M., Humphreys, J. N., Chang, D. T., & Pollom, E. L. (2021). Longitudinal Analysis of Mental Disorder Burden Among Elderly Patients With Gastrointestinal Malignancies. Journal of the National Comprehensive Cancer Network : JNCCN, 1–9.

Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma.
Xiang, M., Holsinger, F. C., Gensheimer, M. F., Divi, V., Pollom, E. L., Colevas, A. D., … Beadle, B. M. (2021). Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma. American Journal of Clinical Oncology, Publish Ahead of Print.

In Regard to Odei etal.
Kahn, J. M., Sandhu, N., & Pollom, E. L. (2021). In Regard to Odei etal. International Journal of Radiation Oncology, Biology, Physics, 109(2), 639–40.

Impact of mental illness on end-of-life emergency department use in elderly patients with gastrointestinal malignancies.
Kashyap, M., Harris, J. P., Chang, D. T., & Pollom, E. L. (2021). Impact of mental illness on end-of-life emergency department use in elderly patients with gastrointestinal malignancies. Cancer Medicine.

A Histologic Low-Grade Glioma with 7 Gain, 10 Loss-A Wolf in Sheep's Clothing.
Pollom, E. L., & Soltys, S. G. (2021). A Histologic Low-Grade Glioma with 7 Gain, 10 Loss-A Wolf in Sheep's Clothing. International Journal of Radiation Oncology, Biology, Physics, 109(5), 1137–38.

Networking and Applying to Radiation Oncology During A Pandemic: Cross-Sectional Survey of Medical Student Concerns.
Pollom, E. L., Sandhu, N., Deig, C. R., Obeid, J.-P., Miller, J. A., & Kahn, J. M. (2021). Networking and Applying to Radiation Oncology During A Pandemic: Cross-Sectional Survey of Medical Student Concerns. Advances in Radiation Oncology, 6(3), 100643.

The Stanford stereotactic radiosurgery experience on 7000 patients over 2 decades (1999-2018): looking far beyond the scalpel.
Fatima, N., Meola, A., Ding, V. Y., Pollom, E., Soltys, S. G., Chuang, C. F., … Chang, S. D. (2021). The Stanford stereotactic radiosurgery experience on 7000 patients over 2 decades (1999-2018): looking far beyond the scalpel. Journal of Neurosurgery, 1–17.

Type of fiducial marker and clinical outcomes in stereotactic body radiation therapy for pancreatic cancer.
Baclay, R. J., Minneci, M., Abid, D., Toesca, D. A. S., von Eyben, R., Pollom, E. L., & Chang, D. T. (2021). Type of fiducial marker and clinical outcomes in stereotactic body radiation therapy for pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY, 39(3).

Radiation Oncology Virtual Education Rotation (ROVER) for Medical Students.
Kahn, J. M., Sandhu, N., von Eyben, R., Deig, C., Obeid, J.-P., Miller, J. A., & Pollom, E. (2021). Radiation Oncology Virtual Education Rotation (ROVER) for Medical Students. International Journal of Radiation Oncology, Biology, Physics.

Time to First Progression in Patients with NSCLC with Brain Metastases Receiving 3rd Generation TKI alone vs TKI plus Brain Radiation
Thomas, N., Myall, N., Sun, F., Patil, T., Mushtaq, R., Yu, C., … Mccoach, C. (2021). Time to First Progression in Patients with NSCLC with Brain Metastases Receiving 3rd Generation TKI alone vs TKI plus Brain Radiation. JOURNAL OF THORACIC ONCOLOGY, 16(3), S591–S592.

Financial Toxicity in Patients with Brain and Spine Metastases.
Koenig, J. L., Sandhu, N., Sborov, K., Sabolch, A., Usoz, M., Li, G., … Pollom, E. L. (2021). Financial Toxicity in Patients with Brain and Spine Metastases. World Neurosurgery.

EXAMINING ASSOCIATIONS AMONG SEXUAL HEALTH, UNMET CARE NEEDS RELATED TO SEXUALITY, AND DISTRESS IN BREAST AND GYNECOLOGIC CANCER SURVIVORS
Benedict, C., Fisher, S., Kuma, D., Pollom, E., Schapira, L., Kurian, A., … Palesh, O. (2021). EXAMINING ASSOCIATIONS AMONG SEXUAL HEALTH, UNMET CARE NEEDS RELATED TO SEXUALITY, AND DISTRESS IN BREAST AND GYNECOLOGIC CANCER SURVIVORS. ANNALS OF BEHAVIORAL MEDICINE. OXFORD UNIV PRESS INC.

Palliative Care Service Utilization and Advance Care Planning for Adult Glioblastoma Patients: A Systematic Review
Wu, A., Ruiz Colón, G., Aslakson, R., Pollom, E., & Patel, C. (2021). Palliative Care Service Utilization and Advance Care Planning for Adult Glioblastoma Patients: A Systematic Review. Cancers, 13(12).

Greater Financial Toxicity Relates to Greater Distress and Worse Quality of Life Among Breast and Gynecologic Cancer Survivors.
Benedict, C., Fisher, S., Schapira, L., Chao, S., Sackeyfio, S., Sullivan, T., … Palesh, O. (2021). Greater Financial Toxicity Relates to Greater Distress and Worse Quality of Life Among Breast and Gynecologic Cancer Survivors. Psycho-Oncology.

#TrendingNow: Instagram versus Twitter Activity Among Radiation Oncology Patients and Providers.
Rahimy, E., Sandhu, N. K., Giao, D. M., & Pollom, E. L. (2021). #TrendingNow: Instagram versus Twitter Activity Among Radiation Oncology Patients and Providers. Practical Radiation Oncology.

Trimodality Versus Bimodality Therapy in Patients With Locally Advanced Esophageal Carcinoma: Commentary on the American Society of Clinical Oncology Practice Guidelines.
Vitzthum, L. K., Hui, C., Pollom, E. L., & Chang, D. T. (2021). Trimodality Versus Bimodality Therapy in Patients With Locally Advanced Esophageal Carcinoma: Commentary on the American Society of Clinical Oncology Practice Guidelines. Practical Radiation Oncology.

Pancreatic Stereotactic Body Radiation Therapy with or without Hypofractionated Elective Nodal Irradiation.
Miller, J. A., Toesca, D. A., Baclay, J. R., Vitzthum, L. K., Dubrowski, P., Pollom, E. L., & Chang, D. T. (2021). Pancreatic Stereotactic Body Radiation Therapy with or without Hypofractionated Elective Nodal Irradiation. International Journal of Radiation Oncology, Biology, Physics.

Brain Metastases in EGFR- and ALK-positive Non-Small Cell Lung Cancer: Outcomes of CNS Penetrant Tyrosine Kinase Inhibitors (TKIs) Alone versus in Combination with Radiation.
Thomas, N. J., Myall, N. J., Sun, F., Patil, T., Mushtaq, R., Yu, C., … McCoach, C. E. (2021). Brain Metastases in EGFR- and ALK-positive Non-Small Cell Lung Cancer: Outcomes of CNS Penetrant Tyrosine Kinase Inhibitors (TKIs) Alone versus in Combination with Radiation. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer.

Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy.
Benson, K. R., Sandhu, N., Zhang, C., Ko, R., Toesca, D. A., Lee, P. E., … Chang, D. T. (2021). Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy. American Journal of Clinical Oncology.

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
Koong, A. J., Toesca, D. A. S., von Eyben, R., Pollom, E. L., & Chang, D. T. (2017). Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma. ADVANCES IN RADIATION ONCOLOGY, 2(1), 27–36.

Intracranial Response to Combination BRAF and MEK Inhibitor Therapy in Patients with Metastatic Melanoma
Hui, C., Wu, Y. (F., Liu, K., Sandhu, N., Blomain, E., Binkley, M., … Pollom, E. (2021). Intracranial Response to Combination BRAF and MEK Inhibitor Therapy in Patients with Metastatic Melanoma. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.

Radiotherapy for Management of Brain Metastases from Thyroid Cancer: A National Cancer Database Study
Blomain, E., Binkley, M., Giao, D., Churilla, T., Soltys, S., & Pollom, E. (2021). Radiotherapy for Management of Brain Metastases from Thyroid Cancer: A National Cancer Database Study. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.

Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes.
Rahimy, E., Dudley, S. A., von Eyben, R., Pollom, E. L., Seiger, K., Modlin, L., … Soltys, S. G. (2021). Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes. American Journal of Clinical Oncology, 44(11), 588–595.

Rectosigmoid Cancer - Rectal Cancer or Sigmoid Cancer?
Hui, C., Baclay, J. R., Liu, K., Sandhu, N., Loo, P., Von Eyben, R., … Pollom, E. (2021). Rectosigmoid Cancer - Rectal Cancer or Sigmoid Cancer? International Journal of Radiation Oncology, Biology, Physics, 111(3S), e47.

A Crowdsourcing Challenge for the Development of Artificial Intelligence Algorithms for Automated Identification and Delineation of Pancreatic Cancer Primary Tumors.
Toesca, D. A., Bush, K., Baclay, J. R., Sergeev, R. A., Brougher, N., Godeny, B., … Chang, D. T. (2021). A Crowdsourcing Challenge for the Development of Artificial Intelligence Algorithms for Automated Identification and Delineation of Pancreatic Cancer Primary Tumors. International Journal of Radiation Oncology, Biology, Physics, 111(3S), e99.

Pathologic Response and Locoregional Control After Preoperative Pancreatic Stereotactic Body Radiation Therapy.
Dworkin, M. L., Miller, J. A., Toesca, D. A., Baclay, J. R., Pollom, E., & Chang, D. T. (2021). Pathologic Response and Locoregional Control After Preoperative Pancreatic Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 111(3S), e37.

The Utility of Stereotactic Body Radiotherapy for Pelvic Recurrences After Prior Radiation Therapy.
Minneci, M., Baclay, J. R., Von Eyben, R., Vitzthum, L., Pollom, E., & Chang, D. T. (2021). The Utility of Stereotactic Body Radiotherapy for Pelvic Recurrences After Prior Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 111(3S), e59–e60.

Analysis of Pathologic Complete Response Rates Between Different Neoadjuvant Radiation Treatment Regimens for Rectal Cancer.
V, A. K., Baclay, J. R., Hui, C., Von Eyben, R., Minneci, M., Loo, P., … Chang, D. T. (2021). Analysis of Pathologic Complete Response Rates Between Different Neoadjuvant Radiation Treatment Regimens for Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics, 111(3S), e52.

Radiation Oncology Virtual Education Rotation 2.0 for Residents: Preliminary Results.
Pollom, E., Sandhu, N., Dieg, C., Miller, J. A., Obeid, J. P., Jimenez, R. B., … Kahn, J. M. (2021). Radiation Oncology Virtual Education Rotation 2.0 for Residents: Preliminary Results. International Journal of Radiation Oncology, Biology, Physics, 111(3S), e184–e185.

The landscape of mortality during or within 30 days after non-palliative radiotherapy across 11 major cancer types.
Xiang, M., Raldow, A. C., Pollom, E. L., Steinberg, M. L., & Kishan, A. U. (2021). The landscape of mortality during or within 30 days after non-palliative radiotherapy across 11 major cancer types. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Palliative care service utilization and advance care planning issues for adult glioblastoma patients: A systematic review.
Wu, A., Colon, G. R., Aslakson, R., Pollom, E. L., & Patel, C. B. (2021). Palliative care service utilization and advance care planning issues for adult glioblastoma patients: A systematic review. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Rectosigmoid Cancer - Rectal Cancer or Sigmoid Cancer?
Hui, C., Baclay, J. R. M., Liu, K., Sandhu, N., Loo, P., Von Eyben, R., … Pollom, E. (2021). Rectosigmoid Cancer - Rectal Cancer or Sigmoid Cancer? INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

A Crowdsourcing Challenge for the Development of Artificial Intelligence Algorithms for Automated Identification and Delineation of Pancreatic Cancer Primary Tumors
Toesca, D. A. S., Bush, K., Baclay, J. R. M., Sergeev, R. A., Brougher, N., Godeny, B., … Chang, D. T. (2021). A Crowdsourcing Challenge for the Development of Artificial Intelligence Algorithms for Automated Identification and Delineation of Pancreatic Cancer Primary Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

Pathologic Response and Locoregional Control After Preoperative Pancreatic Stereotactic Body Radiation Therapy
Dworkin, M. L., Miller, J. A., Toesca, D. A. S., Baclay, J. R., Pollom, E., & Chang, D. T. (2021). Pathologic Response and Locoregional Control After Preoperative Pancreatic Stereotactic Body Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

The Utility of Stereotactic Body Radiotherapy for Pelvic Recurrences After Prior Radiation Therapy
Minneci, M., Baclay, J. R. M., Von Eyben, R., Vitzthum, L., Pollom, E., & Chang, D. T. (2021). The Utility of Stereotactic Body Radiotherapy for Pelvic Recurrences After Prior Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

Analysis of Pathologic Complete Response Rates Between Different Neoadjuvant Radiation Treatment Regimens for Rectal Cancer
Koong, A., Baclay, J. R. M., Hui, C., Von Eyben, R., Minneci, M., Loo, P., … Chang, D. T. (2021). Analysis of Pathologic Complete Response Rates Between Different Neoadjuvant Radiation Treatment Regimens for Rectal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

Radiation Oncology Virtual Education Rotation 2.0 for Residents: Preliminary Results
Pollom, E., Sandhu, N., Dieg, C., Miller, J. A., Obeid, J. P., Jimenez, R. B., … Kahn, J. M. (2021). Radiation Oncology Virtual Education Rotation 2.0 for Residents: Preliminary Results. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.

Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies.
Myall, N. J., Yu, H., Soltys, S. G., Wakelee, H. A., & Pollom, E. (2021). Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies. Neuro-Oncology Advances, 3(Suppl 5), v52–v62.

Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer.
Xiang, M., Chang, A. J., Chamie, K., Drakaki, A., Pollom, E. L., Steinberg, M. L., & Kishan, A. U. (2021). Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer. Clinical Genitourinary Cancer.

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.
Xiang, M., Ma, T. M., Savjani, R., Pollom, E. L., Karnes, R. J., Grogan, T., … Kishan, A. U. (1800). Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. JAMA Network Open, 4(12), e2138550.

Progression Versus Radiation Treatment Changes After Stereotactic Ablative Radiation Therapy of a Liver Metastasis
No, H. J., Negrete, L. M., Pollom, E. L., Wakelee, H. A., Chang, D. T., & Vitzthum, L. K. (2022). Progression Versus Radiation Treatment Changes After Stereotactic Ablative Radiation Therapy of a Liver Metastasis. PRACTICAL RADIATION ONCOLOGY, 12(1), 1–2.

Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types.
Xiang, M., Raldow, A. C., Pollom, E. L., Steinberg, M. L., & Kishan, A. U. (1800). Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology.

In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?"
Thomas, N. J., Myall, N. J., Sun, F., Patil, T., Mushtaq, R., Yu, C., … McCoach, C. E. (1800). In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?". Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 17(2), e12–e14.

RADIOTHERAPY FOR BRAIN METASTASES FROM THYROID CANCER: A RETROSPECTIVE COHORT STUDY
Blomain, E., Berta, S., Hug, N., Giao, D., Meola, A., Binkley, M., … Pollom, E. (2021). RADIOTHERAPY FOR BRAIN METASTASES FROM THYROID CANCER: A RETROSPECTIVE COHORT STUDY. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.

Radiotherapy for brain metastases from thyroid cancer: an institutional and national retrospective cohort study.
Blomain, E. S., Berta, S., Hug, N. F., Giao, D. M., Meola, A., Binkley, M. S., … Pollom, E. L. (2022). Radiotherapy for brain metastases from thyroid cancer: an institutional and national retrospective cohort study. Thyroid : Official Journal of the American Thyroid Association.

Post-operative Stereotactic Radiosurgery of Malignant Melanotic Schwannoma.
Hall, J. C., Chang, S. D., Wilson, T. J., Ganjoo, K. N., Toland, A., Vogel, H., … Rahimy, E. (2022). Post-operative Stereotactic Radiosurgery of Malignant Melanotic Schwannoma. Cureus, 14(3), e22849.

Phase II trial of organ preservation program using short-course radiation and folfoxiri for rectal cancer (SHORT-FOX)
Pollom, E. L., Shelton, A., Fisher, G. A., Bien, J., King, D., Johnson, T. P., … Chang, D. T. (2022). Phase II trial of organ preservation program using short-course radiation and folfoxiri for rectal cancer (SHORT-FOX). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

DSC perfusion MRI-derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery.
‡Kuo, F., ‡Ng, N. N., Nagpal, S., Pollom, E. L., Soltys, S., Hayden-Gephart, M., … Iv, M. (2022). DSC perfusion MRI-derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery. American Journal of Neuroradiology, 43(5).

Impact of socio-economic factors on radiation treatment after resection of metastatic brain tumors: trends from a private insurance database.
Dadey, D. Y., Rodrigues, A., Haider, G., Pollom, E. L., Adler, J. R., & Veeravagu, A. (2022). Impact of socio-economic factors on radiation treatment after resection of metastatic brain tumors: trends from a private insurance database. Journal of Neuro-Oncology.

Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms.
No, H. J., Raja, N., Von Eyben, R., Das, M., Roy, M., Myall, N., … Vitzthum, L. K. (2022). Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms. International Journal of Radiation Oncology, Biology, Physics.

Neoadjuvant therapy in the post-German rectal trial era: making sense in the absence of consensus.
Hui, C., Vitzthum, L. K., Chang, D. T., & Pollom, E. L. (2022). Neoadjuvant therapy in the post-German rectal trial era: making sense in the absence of consensus. Practical Radiation Oncology.

Rectosigmoid Cancer-Rectal Cancer or Sigmoid Cancer?
Hui, C., Baclay, R., Liu, K., Sandhu, N., Loo, P., von Eyben, R., … Pollom, E. (2022). Rectosigmoid Cancer-Rectal Cancer or Sigmoid Cancer? American Journal of Clinical Oncology.

Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer Survivors.
Benedict, C., Fisher, S., Kumar, D., Pollom, E., Schapira, L., Kurian, A. W., … Palesh, O. (2022). Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer Survivors. Seminars in Oncology Nursing, 151316.

Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
Miller, J. A., Moradi, F., Sundaram, V., Liang, R., Zhang, C., Nguyen, N. K., … Gensheimer, M. F. (2022). Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma. Head & Neck.

Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With Cancer.
Taparra, K., Qu, V., & Pollom, E. (2022). Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With Cancer. JAMA Network Open, 5(8), e2226327.

Editorial: Atypical and malignant meningioma: Advances in pathophysiology, imaging and treatment.
Ahmad, M., Meola, A., & Pollom, E. (2022). Editorial: Atypical and malignant meningioma: Advances in pathophysiology, imaging and treatment. Frontiers in Neurology, 13, 970394.

Brain Metastases from Gynecologic Primary Cancers: Prognostic Factors for Local Control and Overall Survival
Mendoza, M., Janchenko, L., von Eyben, R., Kidd, E., Pollom, E., Chang, S., … Soltys, S. (2022). Brain Metastases from Gynecologic Primary Cancers: Prognostic Factors for Local Control and Overall Survival. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.

Intracranial and Metastatic Solitary Fibrous Tumors Treated with Radiotherapy and Radiosurgery
Mendoza, M., Hui, C., von Eyben, R., Pollom, E., Loo, B., & Soltys, S. (2022). Intracranial and Metastatic Solitary Fibrous Tumors Treated with Radiotherapy and Radiosurgery. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.

Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer.
Brant, A., Lewicki, P., Xiang, M., Zhu, A., Kishan, A. U., Pollom, E. L., & Shoag, J. E. (2022). Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer. JAMA Network Open, 5(9), e2231101.

Radiation Oncology Virtual Education Rotation (ROVER) 2.0 for Residents: Implementation and Outcomes.
Sandhu, N. K., Rahimy, E., Hutten, R., Shukla, U., Rajkumar-Calkins, A., Miller, J. A., … Kahn, J. M. (2022). Radiation Oncology Virtual Education Rotation (ROVER) 2.0 for Residents: Implementation and Outcomes. Journal of Cancer Education : the Official Journal of the American Association for Cancer Education.

Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer.
Hui, C., Qu, V., Wang, J.-Y. Y., von Eyben, R., Chang, Y.-C. C., Chiang, P.-L. L., … Pollom, E. (2022). Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer. Journal of Neuro-Oncology.

Stereotactic radiosurgery for trigeminal neuralgia secondary to tumor: a single-institution retrospective series.
Hall, J. C., Ung, T. H., McCleary, T.-L. L., Chuang, C., Gibbs, I. C., Soltys, S. G., … Meola, A. (2022). Stereotactic radiosurgery for trigeminal neuralgia secondary to tumor: a single-institution retrospective series. Neurosurgical Focus, 53(5), E3.

Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity.
Wang, E., Gutkin, P. M., Oh, J., Pollom, E., Soltys, S. G., Grant, G. A., … Hiniker, S. M. (2022). Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity. Neurosurgical Focus, 53(5), E2.

Reflections on the 2021 Accreditation Council for Graduate Medical Education and American Board of Radiology Family and Medical Leave of Absence Policies: An Opportunity to Increase Structural Support for Physicians.
Baniel, C. C., Klebaner, D., Beadle, B. M., Ponce, S. E., Takiar, V., Gibbs, I. C., … Pollom, E. L. (2023). Reflections on the 2021 Accreditation Council for Graduate Medical Education and American Board of Radiology Family and Medical Leave of Absence Policies: An Opportunity to Increase Structural Support for Physicians. International Journal of Radiation Oncology, Biology, Physics, 115(1), 19–22.

Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma.
Hui, C., Wu, Y. F., Liu, K., Sandhu, N., Blomain, E., Binkley, M. S., … Pollom, E. (2022). Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma. Cureus, 14(11), e31838.

Stereotactic radiosurgery for localized cranial Langerhans cell histiocytosis: A single institution experience and review of literature.
Park, D. J., Marianayagam, N. J., Yener, U., Wang, L., Soltys, S. G., Pollom, E., … Meola, A. (2023). Stereotactic radiosurgery for localized cranial Langerhans cell histiocytosis: A single institution experience and review of literature. World Neurosurgery.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer »

Specializing In

Practice Locations

Radiation Oncology at Blake Wilbur Building Palo Alto, CA

Palo Alto, CA

Radiation Oncology at Blake Wilbur Building

875 Blake Wilbur Drive

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information »

Neurogenetic Cancer Palo Alto, CA

Palo Alto, CA

(14 Ratings)

Overall Rating

4.7/5

View Ratings by Category

4.6/5

Friendliness

4.7/5

Explanations

4.8/5

Listens

4.8/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

4.3/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(38 reviews)

We appreciate being able to talk to Dr. Pollom directly. Not being able to speak with the doctor directly leaves a sense that something can and will be lost in translation.

Nov 2022

•

Verified SHC Patient

Very easy to talk with and answered my questions very throughly. She is very pleasant to speak to.

Nov 2022

•

Verified SHC Patient

Dr Pollom is excellent. Blessed to have her as one of my Docs.

Nov 2022

•

Verified SHC Patient

She listens.

Nov 2022

•

Verified SHC Patient

I am very satisfied with Erqi Pollom as my Doctor concerning my cancer treatment and follow up attention she have given me. I fell very comfortable communicating with her about about how I am doing post treatment. I wish other health care providers were as attentive.

Oct 2022

•

Verified SHC Patient

Dr Pollom and her crew got me through cancer treatment and then on to a cure!! I love her.

Aug 2022

•

Verified SHC Patient

This was the most uplifting meeting weâ€™ve had thus far, so we appreciate Dr. Pollom taking the time to look into other trials and being open to experimental treatment.

Aug 2022

•

Verified SHC Patient

She is very knowledgeable and answered the questions I had regarding procedure.

Jul 2022

•

Verified SHC Patient

Extremely helpful

Jun 2022

•

Verified SHC Patient

video visit was helpful and Erqi Pollom very nice and helpful and explained us everything we asked. Very much satisfied. Everyone in the video visit team was helpful, very much appreciated.

Jun 2022

•

Verified SHC Patient

Was though. Answered all our questions.

Jun 2022

•

Verified SHC Patient

Dr. Pollom is a good doctor. She always care for her patient and does the best she can

May 2022

•

Verified SHC Patient

Pues es una doctora exelente y estoy muy feliz de ser su pasiente y es muy amable

Apr 2022

•

Verified SHC Patient

She is a very knowledgeable, helpful doctor along with her staff.

Apr 2022

•

Verified SHC Patient

Wonderful working with her staff and her!

Apr 2022

•

Verified SHC Patient

Like everyone at Stanford Health, Dr. Pollom explained things thoroughly in a warm and friendly way.

Apr 2022

•

Verified SHC Patient

very accommodating and thorough

Mar 2022

•

Verified SHC Patient

I will be going with Dr. POLLOM

Jan 2022

•

Verified SHC Patient

I'm very comfortable with her as my care provide in this matter.

Nov 2021

•

Verified SHC Patient

She seems like a very excellent doctor. She listened well and answered all my questions. I felt like l had a plan and direction after speaking with her.

Nov 2021

•

Verified SHC Patient

Professional and personable.

Oct 2021

•

Verified SHC Patient

An outstanding physician who explains medical issues extremely well.

Oct 2021

•

Verified SHC Patient

Excellent person to talk to.

Oct 2021

•

Verified SHC Patient

Dr Pollom is very attentive and professional and very knowledgeable.very pleasant to talk to.

Jul 2021

•

Verified SHC Patient

Dr. Pollom is a caring radiologist. Iâ€™m grateful to her and her team for my care.

Jun 2021

•

Verified SHC Patient

Dr Pollom is great. I feel comfortable with her knowledge base & truly appreciate her professionalism. She strives to understand what I am saying, and immediately follows up thru her team for â€œnext stepsâ€ .!

May 2021

•

Verified SHC Patient

We recently meet last last year... so far...it has pleasant to work with her...

May 2021

•

Verified SHC Patient

Dr Pollom is very professional yet friendly and approachable. I have the utmost confidence in the care she provides and am thankful to have her on my team.

Apr 2021

•

Verified SHC Patient

Dr. Pollom is very personable and easy to understand.

Dec 2020

•

Verified SHC Patient

Dr. Pollom is very kind and caring.

Jul 2020

•

Verified SHC Patient

Dr. Pollom is perfect!

Apr 2020

•

Verified SHC Patient

Good experience.

Mar 2020

•

Verified SHC Patient

Dr. Pollom is always excellent in every visit I have had with her. She is thorough, friendly, and smart. I am grateful for the help she provided me.

Dec 2019

•

Verified SHC Patient

Good experience. Care provider was very helpful.

Nov 2019

•

Verified SHC Patient

Dr. Pollom is an angel! As are her residents and nurses.

Oct 2019

•

Verified SHC Patient

Thank-you, for all there help.

Oct 2019

•

Verified SHC Patient

If only care providers EVERYWHERE were this good!

Feb 2019

•

Verified SHC Patient

I received radiation treatment last summer from Dr. Pollom. I felt completely happy with my entire treatment. Dr. Pollom, the radiation staff, and people at check in areas were all excellent at their jobs.

Nov 2018

•

Verified SHC Patient

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or e-mail the Referral Center at ReferralCenter@stanfordhealthcare.org

Send referrals online
View referral status
Access medical records

Learn More About PRISM » LOG INTO PRISM

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Erqi Pollom

Radiation oncologist

Get In Touch

Professional Summary

Professional Education

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Radiation Oncology at Blake Wilbur Building Palo Alto, CA

Radiation Oncology at Blake Wilbur Building

Neurogenetic Cancer Palo Alto, CA

Neurogenetic Cancer

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

Endocrine Tumor Program - 875 Blake Wilbur Drive Palo Alto, CA

Endocrine Tumor Program - 875 Blake Wilbur Drive

Brain and Spine Tumor Center at Stanford Cancer Center Palo Alto, CA

Brain and Spine Tumor Center at Stanford Cancer Center

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur Palo Alto, CA

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur

Patient Ratings

How Our Ratings Work

Patient Reviews

(38 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Erqi Pollom

Radiation oncologist

Get In Touch

Professional Summary

Professional Education

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Radiation Oncology at Blake Wilbur Building Palo Alto, CA

Radiation Oncology at Blake Wilbur Building

Neurogenetic Cancer Palo Alto, CA

Neurogenetic Cancer

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

Endocrine Tumor Program - 875 Blake Wilbur Drive Palo Alto, CA

Endocrine Tumor Program - 875 Blake Wilbur Drive

Brain and Spine Tumor Center at Stanford Cancer Center Palo Alto, CA

Brain and Spine Tumor Center at Stanford Cancer Center

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur Palo Alto, CA

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur

Patient Ratings

How Our Ratings Work

Patient Reviews

(38 reviews)

Referring Physicians

PHYSICIAN HELPLINE